Add BrightSurf on Google Email

Predicting pain with machine learning

A machine learning model developed by researchers at Washington University in St. Louis can predict the risk of persistent post-operative pain and provide uncertainty estimates for each prediction. The model achieves better performance than other prediction algorithms and offers a valuable tool for doctors to guide their decisions.

SourceWashington University in St. Louis·JournalProceedings of the ACM on Interactive Mobile Wearable and Ubiquitous Technologies·DateJun 19, 2025

Alcohol-associated liver disease mortality

This cross-sectional study reveals a substantial rise in alcohol-associated liver disease mortality, particularly among women and younger adults. The findings highlight the importance of targeted public health initiatives to address this growing health concern.

SourceJAMA Network·JournalJAMA Network Open·DateJun 11, 2025

Combination finerenone and empagliflozin shows superior efficacy in reducing albuminuria in chronic kidney disease and type 2 diabetes patients

The CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to significantly greater reductions in albuminuria than either agent alone. The study shows a 52% median reduction in urinary albumin-to-creatinine ratio, achieving the ADA-recommended target for 70% of patients.

SourceBeyond·JournalNew England Journal of Medicine·DateJun 5, 2025

Clinical trial and multi-omics analysis demonstrates the impact of therapeutic plasma exchange on biological age

A first-of-its-kind clinical trial demonstrates the impact of therapeutic plasma exchange on biological age, reducing it by an average of 2.6 years. The study used multi-omics biomarkers to investigate the effects of TPE on biological age and found promising results for its potential in disease prevention and longevity applications.

SourceBuck Institute for Research on Aging·JournalAging Cell·TypeRandomized controlled/clinical trial·DateMay 28, 2025

Study says original COVID-19 vaccination did not stop immune system from fighting variants

A study by researchers at the University of Arizona Health Sciences found that vaccinated people generated an overall protective immune response to Delta and Omicron strains, with slightly fewer antibodies for the mutated parts of the virus. The research suggests that immune changes due to antigenic imprinting may not be a significant ...

SourceUniversity of Arizona Health Sciences·JournalNature Immunology·TypeObservational study·DateMay 27, 2025

More young adults than ever take HIV-prevention medication, but gaps remain

A new study found that eight times more American young adults now take HIV-prevention medication than a decade ago, but inconsistent use and barriers persist. PrEP can reduce the chances of acquiring HIV by 99%, emphasizing the need for healthcare providers and public health agencies to promote consistent use among high-risk patients.

SourceMichigan Medicine - University of Michigan·JournalJournal of General Internal Medicine·TypeData/statistical analysis·DateMay 23, 2025

Nicotine pouch and e-cigarette use and co-use among U.S. youths

A cross-sectional study finds a doubling in nicotine pouch past-30-day use and an increase in pouch plus e-cigarette dual use, leading to decreased exclusive e-cigarette use among US 10th and 12th graders. Prioritizing surveillance, regulation, and prevention strategies is crucial for addressing pediatric nicotine pouch use.

SourceJAMA Network·JournalJAMA Network Open·DateApr 30, 2025

Retinal clues to mental health

A recent study by the University of Zurich examined the connection between retinal nerve connections and schizophrenia. The researchers found that individuals with a higher genetic risk for schizophrenia tend to have thinner retinas, which can be detected using non-invasive retinal measurements.

SourceUniversity of Zurich·JournalNature Mental Health·TypeExperimental study·DateApr 22, 2025

A unique sound alleviates motion sickness

Researchers at Nagoya University have discovered a unique sound stimulation technology that alleviates motion sickness, reducing symptoms by up to a minute of stimulation. The device stimulates the inner ear with a specific wavelength of sound, activating the vestibular system and improving balance.

SourceNagoya University·JournalEnvironmental Health and Preventive Medicine·DateApr 4, 2025

Results of the INHALE-3 extension study: inhaled technosphere insulin plus insulin degludec in T1D

The INHALE-3 extension study found that a regimen of inhaled technosphere insulin and insulin degludec reduced post-meal hyperglycemia in adults with type 1 diabetes. The treatment showed significant improvements in mean time in range, with 43% of participants expressing interest in continuing the regimen.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalDiabetes Technology & Therapeutics·TypeRandomized controlled/clinical trial·DateMar 22, 2025